Medline Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDLN research report →
Range $42 – $60
Price Chart
About the company
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide.
- CEO
- James Boyle
- IPO
- 2025
- Employees
- 45,000
- HQ
- Northfield, IL, US
Get TickerSpark's AI analysis on MDLN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $32.77B
- P/E
- 32.02
- Fwd P/E
- 25.58
- PEG
- 12.60
- P/S
- 1.12
- P/B
- 2.82
- EV/EBITDA
- 15.81
- Div Yield
- 0.00%
- Gross Margin
- 24.04%
- Op Margin
- 7.04%
- Net Margin
- 3.31%
- ROE
- 6.87%
- ROIC
- 5.01%
Latest fiscal year · YoY change
- Revenue
- $28.43B+11.5%
- Gross Profit
- $7.52B+19.5%
- Op Income
- $2.21B
- Net Income
- $1.16B-3.4%
- EPS
- $1.43-5.9%
- OCF Growth
- -1.4%
- FCF Growth
- -7.7%
- 52W High
- $50.88
- 52W Low
- $32.81
- 50D MA
- $37.75
- 200D MA
- $41.99
- Beta
- -0.42
- RSI (14)
- 49
- Avg Volume
- 9.67M
No earnings-call transcripts are available for MDLN yet.
- Free Float
- 63.9%
- Shares Outstanding
- 845.61M
- Float Shares
- 540.04M
of shares held by institutions
328 13F filers
Buy/sell ratio 0.27. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Carlyle Group Inc. | 187.08M | ▼ 28.22M |
| H&F Corporate Investors X, Ltd. | 86.47M | ▼ 13.04M |
| Fmr LLC | 36.56M | ▲ 10.20M |
| Capital Research Global Investors | 23.16M | ▲ 8.38M |
| Invesco Ltd. | 20.96M | ▲ 18.43M |
| Vanguard Group Inc | 18.89M | ▲ 18.89M |
| Blackrock, Inc. | 16.92M | ▲ 5.41M |
| Egerton Capital (Uk) Llp | 16.47M | ▲ 12.11M |
| Morgan Stanley | 15.70M | ▲ 540.84K |
| Lone Pine Capital LLC | 11.79M | ▲ 72.46K |
| Massachusetts Financial Services Co | 11.57M | ▲ 1.34M |
| Janus Henderson Group PLC | 11.45M | ▲ 887.24K |
Held by 469 ETFs
Biggest fund positions in MDLN by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 28, 26 | BCP 8 Holdings Mozart Manager L.L.C. | sell | 19,712,326 |
| May 28, 26 | BCP 8 Holdings Mozart Manager L.L.C. | sell | 2,256,800 |
| May 28, 26 | BCP 8 Holdings Mozart Manager L.L.C. | other | 438,214 |
| May 28, 26 | BCP 8 Holdings Mozart Manager L.L.C. | sell | 9,858,774 |
| May 28, 26 | BCP 8 Holdings Mozart Manager L.L.C. | sell | 1,489,924 |
| May 21, 26 | BCP 8 Holdings Mozart Manager L.L.C. | other | 9,858,774 |
| May 21, 26 | BCP 8 Holdings Mozart Manager L.L.C. | other | 9,858,774 |
| May 21, 26 | BCP 8 Holdings Mozart Manager L.L.C. | other | 9,858,774 |
| May 21, 26 | BCP 8 Holdings Mozart Manager L.L.C. | other | 1,489,924 |
| May 21, 26 | BCP 8 Holdings Mozart Manager L.L.C. | other | 1,489,924 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MDLN coverage
Recent articles, reports, and earnings notes.
Medline (MDLN): Scale and Retention Support a Buy
Medline is growing at scale with strong customer retention and a deep med-surg distribution network, but margin pressure and a rich valuation keep the stock from looking cheap.
Medline Inc. (MDLN) drops 7.7% after Q1 margin hit
Medline Inc. (MDLN) drops sharply after its Q1 2026 earnings report showed strong revenue growth but weaker profitability. Investors are reacting to margin compression from tariffs, higher operating costs, and IPO-related expenses, even as full-year sales guidance improved.
Want a deeper read on MDLN?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Kaplan Fox Encourages Investors of Medline Inc. (MDLN) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation
newsfilecorp.com · Jul 24
Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
prnewswire.com · Jul 20
Kaplan Fox Announces a Securities Investigation into Medline Inc. (MDLN) - Investors Encouraged to Contact the Firm
newsfilecorp.com · Jul 20
Kaplan Fox Alerts Medline Inc. (MDLN) Investors to an Investigation of Potential Securities Law Violations
newsfilecorp.com · Jul 17
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Industries, Inc. - MDLN
prnewswire.com · Jul 9
MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations
prnewswire.com · Jul 7
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Industries, Inc. - MDLN
globenewswire.com · Jul 7
Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
gurufocus.com · Jul 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
Bullish or bearish?
Where do you stand on MDLN?